208 related articles for article (PubMed ID: 28265003)
1. SorLA in Interleukin-6 Signaling and Turnover.
Larsen JV; Petersen CM
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28265003
[TBL] [Abstract][Full Text] [Related]
2. SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry.
Larsen JV; Petersen CM
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117780
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
Lacroix M; Rousseau F; Guilhot F; Malinge P; Magistrelli G; Herren S; Jones SA; Jones GW; Scheller J; Lissilaa R; Kosco-Vilbois M; Johnson Z; Buatois V; Ferlin W
J Biol Chem; 2015 Nov; 290(45):26943-26953. PubMed ID: 26363066
[TBL] [Abstract][Full Text] [Related]
4. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.
Gliemann J; Hermey G; Nykjaer A; Petersen CM; Jacobsen C; Andreasen PA
Biochem J; 2004 Jul; 381(Pt 1):203-12. PubMed ID: 15053742
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
6. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-Like Factor 1, an Essential Facilitator of Cardiotrophin-Like Cytokine:Ciliary Neurotrophic Factor Receptor α Signaling and sorLA-Mediated Turnover.
Larsen JV; Kristensen AM; Pallesen LT; Bauer J; Vægter CB; Nielsen MS; Madsen P; Petersen CM
Mol Cell Biol; 2016 Apr; 36(8):1272-86. PubMed ID: 26858303
[TBL] [Abstract][Full Text] [Related]
8. HSPA12A targets the cytoplasmic domain and affects the trafficking of the Amyloid Precursor Protein receptor SorLA.
Madsen P; Isaksen TJ; Siupka P; Tóth AE; Nyegaard M; Gustafsen C; Nielsen MS
Sci Rep; 2019 Jan; 9(1):611. PubMed ID: 30679749
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and its receptor: from bench to bedside.
Scheller J; Rose-John S
Med Microbiol Immunol; 2006 Dec; 195(4):173-83. PubMed ID: 16741736
[TBL] [Abstract][Full Text] [Related]
10. Dissecting Interleukin-6 Classic- and Trans-Signaling in Inflammation and Cancer.
Garbers C; Rose-John S
Methods Mol Biol; 2018; 1725():127-140. PubMed ID: 29322414
[TBL] [Abstract][Full Text] [Related]
11. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
13. Trans-signaling of interleukin-6 (IL-6) is mediated by the soluble IL-6 receptor, but not by soluble CD5.
Aparicio-Siegmund S; Deseke M; Lickert A; Garbers C
Biochem Biophys Res Commun; 2017 Mar; 484(4):808-812. PubMed ID: 28159554
[TBL] [Abstract][Full Text] [Related]
14. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice.
Braun O; Dewitz C; Möller-Hackbarth K; Scheller J; Schiffelholz T; Baier PC; Rose-John S
J Interferon Cytokine Res; 2013 May; 33(5):254-60. PubMed ID: 23215755
[TBL] [Abstract][Full Text] [Related]
15. SorLA controls neurotrophic activity by sorting of GDNF and its receptors GFRα1 and RET.
Glerup S; Lume M; Olsen D; Nyengaard JR; Vaegter CB; Gustafsen C; Christensen EI; Kjolby M; Hay-Schmidt A; Bender D; Madsen P; Saarma M; Nykjaer A; Petersen CM
Cell Rep; 2013 Jan; 3(1):186-99. PubMed ID: 23333276
[TBL] [Abstract][Full Text] [Related]
16. SORLA attenuates EphA4 signaling and amyloid β-induced neurodegeneration.
Huang TY; Zhao Y; Jiang LL; Li X; Liu Y; Sun Y; Piña-Crespo JC; Zhu B; Masliah E; Willnow TE; Pasquale EB; Xu H
J Exp Med; 2017 Dec; 214(12):3669-3685. PubMed ID: 29114064
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
Rose-John S; Scheller J; Elson G; Jones SA
J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
[TBL] [Abstract][Full Text] [Related]
18. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers.
Rose-John S; Schooltink H
Recent Results Cancer Res; 2007; 174():57-66. PubMed ID: 17302185
[TBL] [Abstract][Full Text] [Related]
19. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
[TBL] [Abstract][Full Text] [Related]
20. SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity.
Schmidt V; Schulz N; Yan X; Schürmann A; Kempa S; Kern M; Blüher M; Poy MN; Olivecrona G; Willnow TE
J Clin Invest; 2016 Jul; 126(7):2706-20. PubMed ID: 27322061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
